## AME: AMETEK, Inc. - XLI: Industrials

### Executive Summary

No thesis match: MRS_10 -1.2% below STRENGTH zone (3.0-6.0%); PEG 2.69 fails VALUE criteria (<1.0). Stock is in no-man's land without clear edge. Caution: momentum weakening (-1.8% MRS).

- **Horizon:** N/A - no position
- **Risk Profile:** N/A - avoiding
- **Stop Type:** Fixed 2xATR ($190.03)
- **If Wrong:** N/A - wait for clearer setup
- **Invalidation:** MRS_10 falling below -5% or breaking key support

### News

- **Articles:** 10
- **Sentiment:** Bullish (Bullish: 3, Bearish: 0)

**1. AMETEK, Inc. $AME Shares Acquired by Panagora Asset Management Inc.**
- Source: MarketBeat | 20251202T123150 | Somewhat-Bullish | Relevance: 99%
- Panagora Asset Management Inc. significantly increased its stake in AMETEK, Inc. by 252.2% in the second quarter, now owning 547,563 shares valued at approximately $99.09 million. This occurred despite recent insider selling by CEO David A. Zapico and Ronald J. Oscher. AMETEK reported strong Q3 earnings, beating analyst estimates, and provided positive guidance for Q4 2025 and FY2025, alongside a declared quarterly dividend.

**2. 3,595,341 Shares in AMETEK, Inc. $AME Purchased by Norges Bank**
- Source: MarketBeat | 20251201T113312 | Bullish | Relevance: 98%
- Norges Bank acquired a significant new stake of 3,595,341 shares in AMETEK, Inc. (NYSE:AME) in the second quarter, valued at approximately $650.6 million and representing about 1.56% ownership. This move comes as AMETEK reported strong quarterly earnings and revenue growth, exceeding analyst consensus. The company has an average "Moderate Buy" rating from analysts with an average price target of $211.00, while insider transactions reveal recent share sales by top executives.

**3. Dixon Mitchell Investment Counsel Inc. Purchases 11,292 Shares of AMETEK, Inc. $AME**
- Source: MarketBeat | 20251201T095416 | Somewhat-Bullish | Relevance: 98%
- Dixon Mitchell Investment Counsel Inc. increased its stake in AMETEK, Inc. (AME) by 2.9%, purchasing an additional 11,292 shares, bringing their total holdings to 398,586 shares valued at $72.13 million. This makes AME the fund's 14th largest holding, comprising 2.8% of its portfolio. The article also notes recent insider selling by CEO David A. Zapico and other insiders, along with supportive analyst ratings and AMETEK's strong financial performance including beating quarterly EPS and revenue estimates and issuing positive FY2025 EPS guidance.

**4. Giverny Capital Inc. Has $180.30 Million Stake in AMETEK, Inc. $AME**
- Source: MarketBeat | 20251130T102526 | Bullish | Relevance: 98%
- Giverny Capital Inc. increased its stake in AMETEK, Inc. to $180.30 million, owning 996,344 shares, which now constitutes 6.2% of its portfolio. AMETEK recently exceeded quarterly earnings estimates and provided positive Q4 and full-year 2025 guidance. Despite significant insider selling by executives, investment institutions collectively own 87.43% of the stock, and analysts maintain a "Moderate Buy" consensus rating.

**5. OMERS ADMINISTRATION Corp Boosts Stock Position in AMETEK, Inc. $AME**
- Source: MarketBeat | 20251202T124019 | Somewhat-Bullish | Relevance: 98%
- OMERS ADMINISTRATION Corp increased its stake in AMETEK, Inc. by 8.4% during Q2 2025, bringing its total holdings to 88,760 shares valued at $16.06 million. Other institutions like Vanguard and T. Rowe also boosted their positions, contributing to 87.43% institutional ownership. CEO David A. Zapico and insider Ronald J. Oscher sold significant shares, resulting in a 0.57% insider ownership, while AMETEK reported strong Q3 earnings, beat revenue estimates, and provided positive Q4 and FY2025 guidance.

### Analyst Activity

**Target Signal:** NEUTRAL (Raises: 1, Lowers: 0)

| Date | Firm | Target | Prior | Change |
|------|------|--------|-------|--------|
| 2025-12-08 | DA Davidson | $240 | $235 | +2% |

**Rating Changes:**

| Date | Firm | Action | Grade |
|------|------|--------|-------|
| 2025-12-08 | DA Davidson | main | Buy |

### Insider Activity (90 days)

| Metric | Value |
|--------|-------|
| Direction | **MIXED** |
| Buys | 2 ($0.91M) |
| Sells | 2 ($0.54M) |

### Institutional Ownership

| Metric | Value |
|--------|-------|
| Total Ownership | 42.0% |
| Smart Money | **BULLISH** |
| Net Flow | 0.0% |
| Buying/Selling | 6 / 4 |

**Top Holders:**
- Vanguard Group Inc: 11.8% (+0.6%)
- Blackrock Inc.: 8.5% (-0.9%)
- Price (T.Rowe) Assoc: 4.3% (-7.3%)
- State Street Corpora: 4.2% (+1.3%)
- JPMORGAN CHASE & CO: 3.6% (+77.0%)

### Key Risks

1. Market regime shift could impact momentum names disproportionately.
2. Sector rotation risk if leadership changes from current market theme.
3. Earnings execution risk on next quarterly report.

### Catalysts

- Broader market risk-on sentiment could lift quality names.
- Year-end positioning and window dressing may support price.

### Fundamentals

PEG ratio 2.69 signals overvaluation risk, limited margin of safety. Forward P/E 24.8x stretched relative to 8% growth. Quality metrics strong (margin 20%). Institutional flow bullish (6 buying vs 4 selling).

| Metric | Value |
|--------|-------|
| Market Cap | $46.3B |
| Beta | 1.05 |
| 52W Range | $145.02 - $204.15 |
| Short Interest | 1.1% |

| Valuation | Value |
|-----------|-------|
| PEG Ratio | 2.69 |
| Forward P/E | 24.8 |
| Current P/E | 26.9 |
| YoY Growth | 8.4% |
| EPS Direction | STABLE |

### Technicals

MRS_10 deteriorating from 0.6% to -1.2% (-1.8% in 5 days), indicating relative weakness vs NASDAQ. Below STRENGTH zone by 4.2pp (needs >3.0% for momentum thesis). Full SMA alignment bullish (above 20/50/200 SMAs). RSI neutral at 57.

| Metric | Value | Signal |
|--------|-------|--------|
| MRS_10 | -1.21% (CS: 51) | Neutral |
| RSI_14 | 57.4 | Neutral |
| MACD Histogram | 0.04 | Bullish |
| vs SMA20 | 1.010x | Above |
| vs SMA50 | 1.037x | Above |
| vs SMA200 | 1.088x | Above |

### Decision

- **Verdict:** AVOID
- **Thesis:** NEUTRAL

### Trade Setup

- **Entry:** $197.29
- **Stop Loss:** $190.03 (3.7% risk)
- **Target:** $204.55 (R:R method)
- **Risk/Reward:** 1.00:1
- **Target Reasoning:** NEUTRAL thesis targets 1.0x risk/reward based on historical edge

### Position Sizing

- **Shares:** 68
- **Position Value:** $13,415.72
- **Portfolio %:** 13.42%
- **Risk Dollars:** $500.00
- **Risk Per Trade:** 0.50%
- **Modifiers:** L1 100% | L2 50% | Combined 0.50x

### Market Context

| Layer | Signal | Modifier |
|-------|--------|----------|
| L1 Macro | NORMAL (MEDIUM) | 1.00x |
| L2 Sector | AVOID (Zone C) | 0.50x |

*NORMAL regime with moderate improvement trajectory. VIX compression from 20.5 to 16.6 over 5 days signals declining fear, while 47% breadth shows narrow but recovering participation. Fed meeting in 6 days creates near-term uncertainty, but AI sector momentum and improving technical setups support selective positioning.*

### Earnings

**Next:** 2026-02-03 (Est: $1.94)

| Quarter | Est | Actual | Surprise |
|---------|-----|--------|----------|
| 2025Q3 | $1.76 | $1.89 | +7.4% |
| 2025Q2 | $1.69 | $1.78 | +5.5% |
| 2025Q1 | $1.69 | $1.75 | +3.5% |
| 2024Q4 | $1.85 | $1.87 | +1.1% |

---
*RULE-based L3 | 2026-01-06 16:36 | MRS_10*